Neurocrine Biosciences reported $57.5M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Aptinyx Inc APTX:US $ -19819000 5.59M
Cytokinetics CYTK:US $ -61.55M 14.45M
Dynavax Technologies DVAX:US $ 4.47M 3.58M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
Exelixis EXEL:US $ 124.89M 126.9M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Prothena PRTA:US $ 27.9M 59.97M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Rigel Pharmaceuticals RIGL:US $ -14.79M 56.06M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Teva Pharmaceutical TEVA:IT 794M 650M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Xoma XOMA:US $ -2.24M 5.14M
YTE INCY:US $ 199.6M 31.06M
Zogenix ZGNX:US $ -58.9M 3.27M